Survival after recurrence of stage I-III breast, colorectal, or lung cancer.

about

Survival after recurrence of stage I-III breast, colorectal, or lung cancer.

Item

http://www.wikidata.org/entity/Q50528546

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Survival after recurrence of stage I-III breast, colorectal, or lung cancer.

@en

Survival after recurrence of stage I-III breast, colorectal, or lung cancer.

@nl

type

Item

label

Survival after recurrence of stage I-III breast, colorectal, or lung cancer.

@en

Survival after recurrence of stage I-III breast, colorectal, or lung cancer.

@nl

prefLabel

Survival after recurrence of stage I-III breast, colorectal, or lung cancer.

@en

Survival after recurrence of stage I-III breast, colorectal, or lung cancer.

@nl

P1476

Survival after recurrence of stage I-III breast, colorectal, or lung cancer.

@en

P2093

Angel M Cronin

http://www.w3.org/2001/XMLSchema#string

Debra P Ritzwoller

http://www.w3.org/2001/XMLSchema#string

Hajime Uno

http://www.w3.org/2001/XMLSchema#string

Mark C Hornbrook

http://www.w3.org/2001/XMLSchema#string

Michael J Hassett

http://www.w3.org/2001/XMLSchema#string

Nikki M Carroll

http://www.w3.org/2001/XMLSchema#string

Paul Fishman

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer.

Development of a comorbidity index using physician claims data.

Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.

Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers.

Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).

Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.

Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome

P304

186-194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CANEP.2017.07.001

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28710943

http://www.w3.org/2001/XMLSchema#string

P932

5572775

http://www.w3.org/2001/XMLSchema#string